Jorge L. Alió del Barrio, MD, PhD, FEBOS-CR, FWCRS; Scott Robbie, MBBS, PhD, MBA, FRCOphth; Marcus Ang, MBBS, PhD; Andrea Montesel, MD; and Jorge L. Alió, MD, PhD, FEBOphth
Advertisement
Articles by Jorge L. Alió del Barrio, MD, PhD, FEBOS-CR, FWCRS; Scott Robbie, MBBS, PhD, MBA, FRCOphth; Marcus Ang, MBBS, PhD; Andrea Montesel, MD; and Jorge L. Alió, MD, PhD, FEBOphth
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retina Society 2026: MCO-010 optogenetic therapy maintains visual acuity gains through 4 years in advanced RP
2
Retina Society 2026: Non-invasive electrical stimulation therapy for intermediate dry AMD: improved retinal health and visual acuity
3
Retina Society 2026: Medium-dose OCU410 gene therapy cuts geographic atrophy progression by up to 32% in phase 2 trial
4
Retina Society 2026: LUGANO secondary data show reduced treatment burden with vorolanib insert despite missed primary end point
5
